Accelerate to discover
Related topics
Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs
Oct 12, 2018
Drug delivery by nanocarriers (NCs) has long been stymied by dominant liver uptake and limited target organ deposition,...
Target large genomic regions with 10x genomics + SageHLS
Oct 9, 2018
With customized Cas9 nucleases, scientists can now isolate specific large genomic DNA fragments with the SageHLS...
Coy anaerobic chambers #1 choice in microbiology
Oct 5, 2018
Used for over 40 years in anaerobic microbiology research, COY chambers are also critical to many other research areas...
Understanding subtle cardiac changes
Oct 3, 2018
Are you working with high ultrasound imaging and are you interesting in VevoStrain application and specific changes in...
IncuCyte webinar: Latest developments in live-cell analysis & advanced cell models
Sep 26, 2018
Biomedical researchers are increasingly using advanced human cell models for translational biology and therapeutic...
EasyTEL+ unique digital platform for single or group-housed subjects e
Sep 24, 2018
EMKA announced major enhancements of its easyTEL+ digital implanted telemetry. No more antennas inside cages,...
Quantitative characterization of metaphase cellular events using 3D imaging cellular events
Sep 20, 2018
In conventional monolayer cell culture systems, cell nuclei show dynamic and cyclic changes in theirshape and height....
A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy
Sep 18, 2018
A polymeric conjugate, composed of a carboxymethyl dextran (CMD) as the backbone and ovalbumin (OVA) as a model foreign...
Mar 22, 2016
The mutations driving cancer create clonal populations that differ not just between cancer patients, but within individual tumors. These mutations contain small but significant populations which may survive treatment and metastasize. The only method to get a complete picture of tumor clonality is by sequencing single cells.
In this webinar, you will learn how you can make breakthrough discoveries in your research using single-cell DNA Sequencing. Dr. Ioannis Ragoussis of McGill University will share his research using single-cell whole exome sequencing to reveal the true heterogeneity and cell lineages present in triple negative breast cancer.
Brand profile
Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
More info at:
www.fluidigm.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
